Specialty code 183500000X · Loma Linda, CA
NPI
1659483345
Since 2006
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
11201 Benton St, VA Loma Linda Healthcare System (119)
Loma Linda, CA, 92357
Phone (909) 825-7084
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$12.1M
3,006 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Lucy S Ung prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 367 prescriptions and refills. In total Lucy S Ung wrote 3,006 Medicare prescriptions that cost $12.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 367 | 905 | 99 | $3.3M |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 227 | 577 | 82 | $10K |
| Ritonavir Generic | 215 | 505 | 52 | $27K |
| Descovy Emtricitabine/Tenofov Alafenam | 190 | 459 | 52 | $965K |
| Prezcobix Darunavir/Cobicistat | 166 | 371 | 38 | $932K |
| Tivicay Dolutegravir Sodium | 164 | 371 | 40 | $956K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 154 | 399 | 41 | $1.4M |
| Juluca Dolutegravir/Rilpivirine | 151 | 367 | 39 | $1.3M |
| Darunavir Generic | 135 | 325 | 35 | $29K |
| Isentress Raltegravir Potassium | 121 | 310 | 32 | $663K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 106 | 280 | 30 | $926K |
| Nevirapine Generic | 99 | 232 | 23 | $3,345 |
| Abacavir-Lamivudine Abacavir Sulfate/Lamivudine | 92 | 248 | 27 | $9,546 |
| Atazanavir Sulfate Generic | 72 | 178 | 19 | $7,530 |
| Isentress Hd Raltegravir Potassium | 63 | 122 | 12 | $261K |
Brand drugs: 1,665 claims; generic drugs: - claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Lucy S Ung were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.